HEPION PHARMACEUTICALS, INC. Number of Operating Segments
HEPION PHARMACEUTICALS, INC. (HEPA) reported Number of Operating Segments of 1 Segment for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes
us-gaap:NumberOfOperatingSegments · last filed 2026-03-12
- HEPION PHARMACEUTICALS, INC. number of operating segments for the quarter ending 2019-03-31 was 100.00%.
pure
| Period end | Number of Operating Segments 3 month |
|---|---|
| 2019-03-31 | 100.00% 10-Q · filed 2019-05-15 |
segment
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2024-03-31 | 1.00 segment 10-Q · filed 2024-05-21 | |||
| 2023-12-31 | 1.00 segment 10-K · filed 2024-04-16 | |||
| 2023-09-30 | 1.00 segment 10-Q · filed 2023-11-20 | |||
| 2023-06-30 | 1.00 segment 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | 1.00 segment 10-Q · filed 2023-05-12 | |||
| 2022-12-31 | 1.00 segment 10-K · filed 2023-04-10 | |||
| 2022-09-30 | 1.00 segment 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | 1.00 segment 10-Q · filed 2022-08-15 | |||
| 2022-03-31 | 1.00 segment 10-Q · filed 2022-05-16 | |||
| 2021-12-31 | 1.00 segment 10-K · filed 2022-04-08 | |||
| 2021-09-30 | 1.00 segment 10-Q · filed 2021-11-15 | |||
| 2021-06-30 | 1.00 segment 10-Q · filed 2021-08-16 | |||
| 2021-03-31 | 1.00 segment 10-Q · filed 2021-05-14 | |||
| 2020-12-31 | 1.00 segment 10-K · filed 2021-03-31 | |||
| 2020-09-30 | 1.00 segment 10-Q · filed 2020-11-16 | |||
| 2020-06-30 | 1.00 segment 10-Q · filed 2020-08-12 | |||
| 2020-03-31 | 1.00 segment 10-Q · filed 2020-06-29 | |||
| 2019-12-31 | 1.00 segment 10-K · filed 2020-05-14 | |||
| 2018-12-31 | 1.00 segment 10-K · filed 2019-03-14 | |||
| 2017-12-31 | 1.00 segment 10-KT · filed 2018-03-26 | |||
| 2017-06-30 | 1.00 segment 10-K · filed 2017-09-28 | |||
| 2016-06-30 | 1.00 segment 10-K · filed 2016-09-28 |
USD
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month |
|---|---|---|---|
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $1.00 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $1.00 10-Q · filed 2019-08-14 |
Segment
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2025-12-31 | 1.00 Segment 10-K · filed 2026-03-12 | |||
| 2025-09-30 | 1.00 Segment 10-Q · filed 2025-11-12 | |||
| 2025-06-30 | 1.00 Segment 10-Q · filed 2025-08-14 | |||
| 2025-03-31 | 1.00 Segment 10-Q · filed 2025-05-19 | |||
| 2024-12-31 | 1.00 Segment 10-K · filed 2025-04-08 | |||
| 2024-09-30 | 1.00 Segment 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |